TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.90$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
22.9% 32.4% 43.7% 39.6% 30.5% 31.5% 35.1%
77.1% 67.6% 56.3% 60.4% 69.5% 68.5% 64.9%
11.4% 3.0% 2.1% 4.5% 7.6% 3.4% 3.2%
83.5% 173.7% 118.7% 87.6% 77.9% 71.1% 74.3%
360.4% 338.4% 100.9% 104.4% 93.9% 81.4% 77.5%
-283.3% -270.7% -44.6% -44.0% -24.4% -12.9% -12.7%
22.8% 18.6% 1.4% 6.1% 6.8% 7.0% 6.6%
-300.8% -288.2% -46.9% -50.0% -30.4% -18.7% -17.1%
-43.0% 0.1% 0.0% 0.1% 0.1% 0.2% 0.2%
-257.8% -288.3% -47.0% -50.1% -30.5% -18.9% -17.4%
-263.7% -256.0% -39.2% -36.2% -20.7% -9.4% -7.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?